[go: up one dir, main page]

NO20053203L - Combination of local ester anesthetics. - Google Patents

Combination of local ester anesthetics.

Info

Publication number
NO20053203L
NO20053203L NO20053203A NO20053203A NO20053203L NO 20053203 L NO20053203 L NO 20053203L NO 20053203 A NO20053203 A NO 20053203A NO 20053203 A NO20053203 A NO 20053203A NO 20053203 L NO20053203 L NO 20053203L
Authority
NO
Norway
Prior art keywords
combination
ester anesthetics
action
analgesia
onset
Prior art date
Application number
NO20053203A
Other languages
Norwegian (no)
Other versions
NO20053203D0 (en
Inventor
Steven L Shafer
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of NO20053203D0 publication Critical patent/NO20053203D0/en
Publication of NO20053203L publication Critical patent/NO20053203L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det tilveiebringes preparater og metoder for forbedret lokalanestesi og/eller analgesi der virkningsstarten er hurtig, risikoen for toksisitet er lav og effekten opprettholdes. Mer spesielt tilveiebringes det en kombinasjon av minst to esteranestetika fot administrering til et individ der minst et esteranestetikum gir en hurtig virkningsstart og minst et gir opprettholdt aktivitet. Preparatene ifølge oppfinnelsen er brukbare for å oppnå analgesi og/eller anestesi og er spesielt nyttige ved profylakse og/eller terapi av smerte.Preparations and methods for improved local anesthesia and / or analgesia are provided where the onset of action is rapid, the risk of toxicity is low and the effect is maintained. More particularly, there is provided a combination of at least two ester anesthetics for administration to an individual where at least one ester anesthetic provides a rapid onset of action and at least one provides sustained activity. The compositions of the invention are useful for achieving analgesia and / or anesthesia and are particularly useful in the prophylaxis and / or therapy of pain.

NO20053203A 2002-12-20 2005-06-30 Combination of local ester anesthetics. NO20053203L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32731002A 2002-12-20 2002-12-20
PCT/US2003/041219 WO2004058329A2 (en) 2002-12-20 2003-12-18 Ester combination local anesthetic

Publications (2)

Publication Number Publication Date
NO20053203D0 NO20053203D0 (en) 2005-06-30
NO20053203L true NO20053203L (en) 2005-09-19

Family

ID=32680753

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053203A NO20053203L (en) 2002-12-20 2005-06-30 Combination of local ester anesthetics.

Country Status (10)

Country Link
EP (1) EP1572218A4 (en)
JP (1) JP2006513224A (en)
KR (1) KR20050085736A (en)
CN (1) CN1729004A (en)
AU (1) AU2003299885A1 (en)
BR (1) BR0317519A (en)
CA (1) CA2507511A1 (en)
MX (1) MXPA05006771A (en)
NO (1) NO20053203L (en)
WO (1) WO2004058329A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060062836A1 (en) * 2004-09-21 2006-03-23 Carter Stephen G Methods of device-assisted drug delivery
WO2006096914A1 (en) 2005-03-15 2006-09-21 Animal Ethics Pty Ltd A topical analgesic composition
ITMI20051633A1 (en) * 2005-09-06 2007-03-07 Sint Sa NEW USE OF A COMPOSITION INCLUDING CHOROPROCAINE HCL NEW COMPOSITION INCLUDING CHLOROPROCAINE HCL AND METHOD FOR ITS MANUFACTURING
EP2069299A2 (en) * 2006-07-19 2009-06-17 Pharmacofore, Inc. Anesthetic compounds
US20080220062A1 (en) * 2006-10-23 2008-09-11 Psivida, Inc. Sustained release of agents for localized pain management
WO2009091546A1 (en) * 2008-01-18 2009-07-23 Pharmacofore, Inc. Anesthetic compounds
ITMI20122120A1 (en) 2012-12-12 2014-06-13 Sint Sa PHARMACEUTICAL COMPOSITION BASED ON CHLOROPROCAIN FOR REPEATED INTRATECAL ADMINISTRATION
ITCR20130004A1 (en) * 2013-02-05 2014-08-06 Vincenzo Vigna SALVAVITA DRUG
US10117847B2 (en) 2015-12-04 2018-11-06 Ventis Pharma Extended duration local anesthetic formulation
DE102016215037B4 (en) 2016-08-11 2024-10-24 Lamello Ag spring device and connecting device
MX2020002898A (en) * 2017-09-15 2020-11-06 Sintetica S A TOPICAL FORMULATIONS OF CHLOROPROCAINE AND METHODS FOR USING THE SAME.
WO2019226599A1 (en) * 2018-05-22 2019-11-28 Alkalidx, Inc. Diagnostics and treatments of anesthetic insensitive subjects
JP6886551B1 (en) * 2020-11-06 2021-06-16 医療法人祥和会 Local anesthetic for dentistry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US6326020B1 (en) * 1997-05-16 2001-12-04 Children's Medical Center Corporation Local anesthetic formulations
AU5286901A (en) * 1999-10-22 2001-06-18 Transdermatech, Inc. Topical anesthetic formulation
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US20020006435A1 (en) * 2000-01-27 2002-01-17 Samuels Paul J. Transdermal anesthetic and vasodilator composition and methods for topical administration

Also Published As

Publication number Publication date
CA2507511A1 (en) 2004-07-15
KR20050085736A (en) 2005-08-29
EP1572218A4 (en) 2007-05-16
NO20053203D0 (en) 2005-06-30
BR0317519A (en) 2005-11-16
EP1572218A2 (en) 2005-09-14
MXPA05006771A (en) 2005-09-08
CN1729004A (en) 2006-02-01
AU2003299885A1 (en) 2004-07-22
WO2004058329A3 (en) 2004-12-29
WO2004058329A2 (en) 2004-07-15
JP2006513224A (en) 2006-04-20

Similar Documents

Publication Publication Date Title
NO20053203L (en) Combination of local ester anesthetics.
NO20056252L (en) Therapeutic and prophylactic methods for neuromuscular disorders
ATE401874T1 (en) ADMINISTRATION OF CAPSAICINOIDS
CY1116463T1 (en) Combination therapy for the therapeutic treatment of Protein Deficiency Disorders
JOP20220179A1 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
EP1605956A4 (en) Administration of capsaicinoids
RS52199B (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
NO20073774L (en) Therapeutic compounds for intranasal administration of ketorolac
NO20065368L (en) Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine
NO20050851L (en) Caspase Inhibitors and Uses thereof
EP1962843A4 (en) USE OF PARP-1 INHIBITORS
NO20045240L (en) Transepicutaneous administration to treat restless legs syndrome
NO20056073L (en) Compositions and Methods for the Treatment of Severe Acute Respiratory Syndrome (SARS)
NO20052272L (en) CCR1 antagonists for the treatment of, among other things, the demylins inflammatory disease
CY1110369T1 (en) NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol
DK1303278T3 (en) Combination of a transdermal therapeutic system and an oral and / or parenteral preparation containing dopamine agonists for the treatment of dopaminergic diseases
NO20050718L (en) Topical treatment of skin diseases
RS95304A (en) New combination fortreating airway disorders
NO20053023L (en) Synergistic combination including roflumilase and (R, R) formoterol
IS8106A (en) Macrolide composition and local anesthetic to treat skin disorders
RS95204A (en) Combination for the treatment of airway disorders
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
UA41154A (en) Germogran-m composition based on oil from wheat germs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application